Selected research
Market Analysis & Forecast
Global Microbiology Software Market Analysis and Forecast 2026-2032
Market perspective
The global Microbiology Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Microbiology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Microbiology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Microbiology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Microbiology Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Microbiology Software include ERBA Diagnostics Mannheim, GSL Biotech, Micronbrane Medical, Synbiosis, Charles River Laboratories, SCC SOFT COMPUTER, Systec GmbH & Co. KG., i2a (intelligence artificielle applications) S.A. and Soft Computer Consultants, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Microbiology Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Microbiology Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Microbiology Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Microbiology Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Microbiology Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Microbiology Software revenue, projected growth trends, production technology, application and end-user industry.
Microbiology Software Segment by Company
ERBA Diagnostics Mannheim
GSL Biotech
Micronbrane Medical
Synbiosis
Charles River Laboratories
SCC SOFT COMPUTER
Systec GmbH & Co. KG.
i2a (intelligence artificielle applications) S.A.
Soft Computer Consultants
Clover Bioanalytical Software
Microbiology Software Segment by Type
Cloud Based
On-Premises
Microbiology Software Segment by Application
Pharmaceutical and Biotechnology Industry
Academic and Research Centers
Hospital
Others
Microbiology Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microbiology Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microbiology Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microbiology Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Microbiology Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Microbiology Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microbiology Software revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud Based
- On-Premises
Applications
- Pharmaceutical and Biotechnology Industry
- Academic and Research Centers
- Hospital
- Others
Companies covered
- ERBA Diagnostics Mannheim
- GSL Biotech
- Micronbrane Medical
- Synbiosis
- Charles River Laboratories
- SCC SOFT COMPUTER
- Systec GmbH & Co. KG.
- i2a (intelligence artificielle applications) S.A.
- Soft Computer Consultants
- Clover Bioanalytical Software
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Microbiology Software Market by Type
- 1.2.1 Global Microbiology Software Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Cloud Based
- 1.2.3 On-Premises
- 1.3 Microbiology Software Market by Application
- 1.3.1 Global Microbiology Software Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical and Biotechnology Industry
- 1.3.3 Academic and Research Centers
- 1.3.4 Hospital
- 1.3.5 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Microbiology Software Market Dynamics
- 2.1 Microbiology Software Industry Trends
- 2.2 Microbiology Software Industry Drivers
- 2.3 Microbiology Software Industry Opportunities and Challenges
- 2.4 Microbiology Software Industry Restraints
3 Global Growth Perspective
- 3.1 Global Microbiology Software Market Perspective (2021-2032)
- 3.2 Global Microbiology Software Growth Trends by Region
- 3.2.1 Global Microbiology Software Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Microbiology Software Market Size by Region (2021-2026)
- 3.2.3 Global Microbiology Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Microbiology Software Revenue by Players
- 4.1.1 Global Microbiology Software Revenue by Players (2021-2026)
- 4.1.2 Global Microbiology Software Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Microbiology Software Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Microbiology Software Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Microbiology Software Key Players Headquarters & Area Served
- 4.4 Global Microbiology Software Players, Product Type & Application
- 4.5 Global Microbiology Software Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Microbiology Software Market CR5 and HHI
- 4.6.3 2025 Microbiology Software Tier 1, Tier 2, and Tier 3
5 Microbiology Software Market Size by Type
- 5.1 Global Microbiology Software Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Microbiology Software Revenue by Type (2021-2032)
- 5.3 Global Microbiology Software Revenue Market Share by Type (2021-2032)
6 Microbiology Software Market Size by Application
- 6.1 Global Microbiology Software Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Microbiology Software Revenue by Application (2021-2032)
- 6.3 Global Microbiology Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 ERBA Diagnostics Mannheim
- 7.1.1 ERBA Diagnostics Mannheim Company Information
- 7.1.2 ERBA Diagnostics Mannheim Business Overview
- 7.1.3 ERBA Diagnostics Mannheim Microbiology Software Revenue and Gross Margin (2021-2026)
- 7.1.4 ERBA Diagnostics Mannheim Microbiology Software Product Portfolio
- 7.1.5 ERBA Diagnostics Mannheim Recent Developments
- 7.2 GSL Biotech
- 7.2.1 GSL Biotech Company Information
- 7.2.2 GSL Biotech Business Overview
- 7.2.3 GSL Biotech Microbiology Software Revenue and Gross Margin (2021-2026)
- 7.2.4 GSL Biotech Microbiology Software Product Portfolio
- 7.2.5 GSL Biotech Recent Developments
- 7.3 Micronbrane Medical
- 7.3.1 Micronbrane Medical Company Information
- 7.3.2 Micronbrane Medical Business Overview
- 7.3.3 Micronbrane Medical Microbiology Software Revenue and Gross Margin (2021-2026)
- 7.3.4 Micronbrane Medical Microbiology Software Product Portfolio
- 7.3.5 Micronbrane Medical Recent Developments
- 7.4 Synbiosis
- 7.4.1 Synbiosis Company Information
- 7.4.2 Synbiosis Business Overview
- 7.4.3 Synbiosis Microbiology Software Revenue and Gross Margin (2021-2026)
- 7.4.4 Synbiosis Microbiology Software Product Portfolio
- 7.4.5 Synbiosis Recent Developments
- 7.5 Charles River Laboratories
- 7.5.1 Charles River Laboratories Company Information
- 7.5.2 Charles River Laboratories Business Overview
- 7.5.3 Charles River Laboratories Microbiology Software Revenue and Gross Margin (2021-2026)
- 7.5.4 Charles River Laboratories Microbiology Software Product Portfolio
- 7.5.5 Charles River Laboratories Recent Developments
- 7.6 SCC SOFT COMPUTER
- 7.6.1 SCC SOFT COMPUTER Company Information
- 7.6.2 SCC SOFT COMPUTER Business Overview
- 7.6.3 SCC SOFT COMPUTER Microbiology Software Revenue and Gross Margin (2021-2026)
- 7.6.4 SCC SOFT COMPUTER Microbiology Software Product Portfolio
- 7.6.5 SCC SOFT COMPUTER Recent Developments
- 7.7 Systec GmbH & Co. KG.
- 7.7.1 Systec GmbH & Co. KG. Company Information
- 7.7.2 Systec GmbH & Co. KG. Business Overview
- 7.7.3 Systec GmbH & Co. KG. Microbiology Software Revenue and Gross Margin (2021-2026)
- 7.7.4 Systec GmbH & Co. KG. Microbiology Software Product Portfolio
- 7.7.5 Systec GmbH & Co. KG. Recent Developments
- 7.8 i2a (intelligence artificielle applications) S.A.
- 7.8.1 i2a (intelligence artificielle applications) S.A. Company Information
- 7.8.2 i2a (intelligence artificielle applications) S.A. Business Overview
- 7.8.3 i2a (intelligence artificielle applications) S.A. Microbiology Software Revenue and Gross Margin (2021-2026)
- 7.8.4 i2a (intelligence artificielle applications) S.A. Microbiology Software Product Portfolio
- 7.8.5 i2a (intelligence artificielle applications) S.A. Recent Developments
- 7.9 Soft Computer Consultants
- 7.9.1 Soft Computer Consultants Company Information
- 7.9.2 Soft Computer Consultants Business Overview
- 7.9.3 Soft Computer Consultants Microbiology Software Revenue and Gross Margin (2021-2026)
- 7.9.4 Soft Computer Consultants Microbiology Software Product Portfolio
- 7.9.5 Soft Computer Consultants Recent Developments
- 7.10 Clover Bioanalytical Software
- 7.10.1 Clover Bioanalytical Software Company Information
- 7.10.2 Clover Bioanalytical Software Business Overview
- 7.10.3 Clover Bioanalytical Software Microbiology Software Revenue and Gross Margin (2021-2026)
- 7.10.4 Clover Bioanalytical Software Microbiology Software Product Portfolio
- 7.10.5 Clover Bioanalytical Software Recent Developments
8 North America
- 8.1 North America Microbiology Software Revenue (2021-2032)
- 8.2 North America Microbiology Software Revenue by Type (2021-2032)
- 8.2.1 North America Microbiology Software Revenue by Type (2021-2026)
- 8.2.2 North America Microbiology Software Revenue by Type (2027-2032)
- 8.3 North America Microbiology Software Revenue Share by Type (2021-2032)
- 8.4 North America Microbiology Software Revenue by Application (2021-2032)
- 8.4.1 North America Microbiology Software Revenue by Application (2021-2026)
- 8.4.2 North America Microbiology Software Revenue by Application (2027-2032)
- 8.5 North America Microbiology Software Revenue Share by Application (2021-2032)
- 8.6 North America Microbiology Software Revenue by Country
- 8.6.1 North America Microbiology Software Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Microbiology Software Revenue by Country (2021-2026)
- 8.6.3 North America Microbiology Software Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Microbiology Software Revenue (2021-2032)
- 9.2 Europe Microbiology Software Revenue by Type (2021-2032)
- 9.2.1 Europe Microbiology Software Revenue by Type (2021-2026)
- 9.2.2 Europe Microbiology Software Revenue by Type (2027-2032)
- 9.3 Europe Microbiology Software Revenue Share by Type (2021-2032)
- 9.4 Europe Microbiology Software Revenue by Application (2021-2032)
- 9.4.1 Europe Microbiology Software Revenue by Application (2021-2026)
- 9.4.2 Europe Microbiology Software Revenue by Application (2027-2032)
- 9.5 Europe Microbiology Software Revenue Share by Application (2021-2032)
- 9.6 Europe Microbiology Software Revenue by Country
- 9.6.1 Europe Microbiology Software Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Microbiology Software Revenue by Country (2021-2026)
- 9.6.3 Europe Microbiology Software Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Microbiology Software Revenue (2021-2032)
- 10.2 China Microbiology Software Revenue by Type (2021-2032)
- 10.2.1 China Microbiology Software Revenue by Type (2021-2026)
- 10.2.2 China Microbiology Software Revenue by Type (2027-2032)
- 10.3 China Microbiology Software Revenue Share by Type (2021-2032)
- 10.4 China Microbiology Software Revenue by Application (2021-2032)
- 10.4.1 China Microbiology Software Revenue by Application (2021-2026)
- 10.4.2 China Microbiology Software Revenue by Application (2027-2032)
- 10.5 China Microbiology Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Microbiology Software Revenue (2021-2032)
- 11.2 Asia Microbiology Software Revenue by Type (2021-2032)
- 11.2.1 Asia Microbiology Software Revenue by Type (2021-2026)
- 11.2.2 Asia Microbiology Software Revenue by Type (2027-2032)
- 11.3 Asia Microbiology Software Revenue Share by Type (2021-2032)
- 11.4 Asia Microbiology Software Revenue by Application (2021-2032)
- 11.4.1 Asia Microbiology Software Revenue by Application (2021-2026)
- 11.4.2 Asia Microbiology Software Revenue by Application (2027-2032)
- 11.5 Asia Microbiology Software Revenue Share by Application (2021-2032)
- 11.6 Asia Microbiology Software Revenue by Country
- 11.6.1 Asia Microbiology Software Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Microbiology Software Revenue by Country (2021-2026)
- 11.6.3 Asia Microbiology Software Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Microbiology Software Revenue (2021-2032)
- 12.2 SAMEA Microbiology Software Revenue by Type (2021-2032)
- 12.2.1 SAMEA Microbiology Software Revenue by Type (2021-2026)
- 12.2.2 SAMEA Microbiology Software Revenue by Type (2027-2032)
- 12.3 SAMEA Microbiology Software Revenue Share by Type (2021-2032)
- 12.4 SAMEA Microbiology Software Revenue by Application (2021-2032)
- 12.4.1 SAMEA Microbiology Software Revenue by Application (2021-2026)
- 12.4.2 SAMEA Microbiology Software Revenue by Application (2027-2032)
- 12.5 SAMEA Microbiology Software Revenue Share by Application (2021-2032)
- 12.6 SAMEA Microbiology Software Revenue by Country
- 12.6.1 SAMEA Microbiology Software Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Microbiology Software Revenue by Country (2021-2026)
- 12.6.3 SAMEA Microbiology Software Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst